// App-Quantinova.ai

e14538 : Converting a tumor from checkpoint blockade-resistant to checkpoint blockade-sensitive: Immunotransplant for aggressive lymphoma.

Researchers

Presenter

  • Netonia Marshall

Principal Investigators

  • Linda Hammerich

  • Ranjan Upadhyay

  • Thomas Urban Marron

  • Joshua Brody

Medical Centers

  • Ichan Medical School at Mt. Sinai Hospital, New York, NY

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Mount Sinai Hospital, New York, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lymphomas

Biomarkers

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved